-
Product Insights
Mast/Stem Cell Growth Factor Receptor Kit – Drugs In Development, 2023
Global Markets Direct’s Mast/Stem Cell Growth Factor Receptor Kit provides in depth analysis on Mast/Stem Cell Growth Factor Receptor Kit targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
Kit Carson
Kit Carson is an Onshore Wind project located in Colorado, United States. The project is owned by Duke Energy Renewables Inc; Manulife Financial Corp and was developed by Duke Energy Renewables Inc. The project came online in 2010. Empower your strategies with our Kit Carson report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Sector Analysis
Major European Soccer Kit Suppliers 2023-24 – Analyzing Sponsorship Deals, League and Brand/Partner Breakdown
Major European Soccer Kit Suppliers Report Overview The Major European Soccer Kit Suppliers 2023-2024 report takes a closer look at the ten largest leagues on the continent this season. The English Premier League remains the most dominant commercial powerhouse in European soccer, with the 20 team values worth an estimated $469.96 million. 41 new deals have been announced across the ten leagues for the 2023-2024 season. The biggest deal in the league remains between Manchester United and Adidas while the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Briquilimab in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Briquilimab in Myelodysplastic Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Briquilimab in Myelodysplastic Syndrome Drug Details: Briquilimab (AMG-191) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Briquilimab in Chronic Urticaria Or Hives
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Briquilimab in Chronic Urticaria Or Hives report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Briquilimab in Chronic Urticaria Or Hives Drug Details: Briquilimab (AMG-191)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Briquilimab in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Briquilimab in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Briquilimab in Acute Myelocytic Leukemia (AML, Acute...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Avapritinib in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avapritinib in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Avapritinib in Breast Cancer Drug Details: Avapritinib (Ayvakit, Ayvakyt) is an anti-neoplastic...
-
Product Insights
NewCardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication. The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pexidartinib Hydrochloride in Sarcomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pexidartinib Hydrochloride in Sarcomas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pexidartinib Hydrochloride in Sarcomas Drug Details: Pexidartinib hydrochloride (Turalio) is an anti-neoplastic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pexidartinib Hydrochloride in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pexidartinib Hydrochloride in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pexidartinib Hydrochloride in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma)...